Caldwell Sutter Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.8K Buy
267
+48
+22% +$4.28K 0.01% 466
2025
Q4
$17.3K Buy
+219
New +$17.2K 0.01% 489
2024
Q3
Sell
-2,251
Closed -$218K 910
2024
Q2
$218K Sell
2,251
-44
-2% -$4.06K 0.11% 180
2024
Q1
$207K Sell
2,295
-27
-1% -$2.29K 0.1% 189
2023
Q4
$185K Buy
2,322
+16
+0.7% +$1.2K 0.09% 200
2023
Q3
$164K Buy
2,306
+53
+2% +$3.96K 0.09% 201
2023
Q2
$174K Buy
2,253
+1,162
+107% +$89.9K 0.09% 194
2023
Q1
$82K Buy
+1,091
New +$81.1K 0.06% 202

Other funds holding CL

Caldwell Sutter Capital's CL Position: Q1 2026 in Review

Caldwell Sutter Capital increased its Colgate-Palmolive (CL) stake by 22% in Q1 2026, buying an estimated $4.28K and bringing the position to 267 shares worth $22.8K. The position accounts for 0.01% of the portfolio, ranked #466.

Caldwell Sutter Capital first reported a position in CL in Q1 2023 and has held it in 8 quarters since. The position peaked at $218K in Q2 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Caldwell Sutter Capital held 267 shares of Colgate-Palmolive worth $22.8K as of Q1 2026.
  • Caldwell Sutter Capital bought 48 Colgate-Palmolive shares in Q1 2026, an estimated $4.28K.
  • Colgate-Palmolive made up 0.01% of Caldwell Sutter Capital's portfolio in Q1 2026, its #466 holding.
  • Caldwell Sutter Capital first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 8 quarters since.
  • Caldwell Sutter Capital's Colgate-Palmolive position peaked at $218K in Q2 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.